Sign up to get helpful information about ZILBRYSQ.

US-ZL-2400081

Actor Portrayals

Home Hero Desktop

For adults with 
GENERALIZED MYASTHENIA 
GRAVIS (gMG)

Image your Zillions
Image your Zillions

Discover the first FDA-approved, self-administered treatment for adults with gMG who are anti-acetylcholine receptor (AChR) antibody positive.

Significantly improves gMG symptoms

In a clinical trial, people taking ZILBRYSQ experienced significant improvements in activities of daily living as measured by Myasthenia Gravis Activities of Daily Living (MG‑ADL).*

See Trial Results 

Rapid improvements in daily living

In the 12-week clinical trial, patients taking ZILBRYSQ experienced significant improvement in activities of daily living such as breathing, talking, swallowing, and being able to rise from a chair.*

Some patients also saw improvements in gMG symptoms as early as Week 1.

View Results

Injected at home 
or away

ZILBRYSQ is self-administered after preparation and proper training.

How to Take ZILBRYSQ

*As determined by improvement in the MG-ADL score from baseline on Week 12 of the study; -4.4 points in the ZILBRYSQ-treated group (86 people) vs -2.3 in the placebo group (88 people). Individual results may vary, and not all people taking ZILBRYSQ will experience improvements.

Get to know ZILBRYSQ

Get educational resources, treatment support, and tools for talking to your doctor sent right to you.

Sign Up Now 

Here for you throughout your treatment

ONWARD® provides personalized support, including help to understand coverage and financial options, tools to help you track symptoms, refresher injection coaching, and guidance when starting and continuing treatment.

Learn More 

ONWARD is provided as a service of UCB and is intended to support the appropriate use of UCB medicines. ONWARD may be amended or canceled at any time without notice. Some program and eligibility restrictions may apply.